THE INNOVATIVE MEDICINES INITIATIVE

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo

 

IMI 2 Open Info Day - registration open

Registration for the IMI 2 Open Info Day on 30 September in Brussels is now open.

Sign up to learn more about the IMI 2 rules and procedures as well as the first Call topics.

ONGOING PROJECTS

  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Get on-course!

    With over 5 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's 46 projects have a combined budget of €1.6 billion and are tackling some of the toughest challenges in drug development.

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Schizophrenia breakthrough

    NEWMEDS project research published in Nature reveals that genetic variants linked with schizophrenia have an impact in healthy carriers

    ... more
All projects

NEW INDICATIVE TOPICS PUBLISHED

The following topics are under consideration for inclusion in future IMI Calls:

  • Remote assessment
  • Type 2 diabetes
  • Neuropsychiatry

Find out more on the Future Topics page

IMI NEWSFLASH IMI News Flash

 
  • 16/09/2014 : RT @Eu2P: Master defense: Trends in the use of #psychotropic #drugs and suicide in France from 2008 to 2011. http://t.co/zrOi3IzZ5z
  • 16/09/2014 : RT @gekirl: @eupatients panel discussion on the necessity of genuine involvement of patients in clinical research #EUPATI #IPPOSI
  • 16/09/2014 : RT @MichelGoldman: Research on #dementia must become global: a major task for the World Dementia Council,G7 and OECD & new hopes for the #A…

Follow us on Twitter